Biotech Snap logo
Biotech Snap
Subscribe
  • Biotech Snap
  • Archive
  • Page 4

Latest news

Capricor’s Duchenne comeback & Triana's $120M molecular glue degrader
Dec 04, 2025

Capricor’s Duchenne comeback & Triana's $120M molecular glue degrader

Joachim Eeckhout
Janux's T-cell therapy misses the mark
Dec 03, 2025

Janux's T-cell therapy misses the mark

Joachim Eeckhout
Belite Bio's Phase 3 success in Stargardt
Dec 02, 2025

Belite Bio's Phase 3 success in Stargardt

Joachim Eeckhout
Otsuka’s first FDA-approved anti-APRIL therapy & Valneva's site closure
Dec 01, 2025

Otsuka’s first FDA-approved anti-APRIL therapy & Valneva's site closure

Joachim Eeckhout
Daily Snap - 26. November 2025
Nov 26, 2025

Daily Snap - 26. November 2025

Joachim Eeckhout
Gilead invests $414M into TREX1 cancer drug from Sprint Bioscience
Nov 26, 2025

Gilead invests $414M into TREX1 cancer drug from Sprint Bioscience

Eduardo Longoria
Daily Snap - 25. November 2025
Nov 25, 2025

Daily Snap - 25. November 2025

Joachim Eeckhout
Novo Nordisk’s Alzheimer’s trials fail, casting doubt on GLP-1 drugs for neurodegeneration
Nov 25, 2025

Novo Nordisk’s Alzheimer’s trials fail, casting doubt on GLP-1 drugs for neurodegeneration

Eduardo Longoria
Versant launches Dayra with $50M Biogen deal to chase oral macrocyclic peptide drugs
Nov 25, 2025

Versant launches Dayra with $50M Biogen deal to chase oral macrocyclic peptide drugs

Eduardo Longoria
Daily Snap - 24. November 2025
Nov 24, 2025

Daily Snap - 24. November 2025

Joachim Eeckhout
Contineum’s multiple sclerosis drug fails phase 2 test, raising doubts on its potential
Nov 24, 2025

Contineum’s multiple sclerosis drug fails phase 2 test, raising doubts on its potential

Eduardo Longoria
Daily Snap - 21. November 2025
Nov 21, 2025

Daily Snap - 21. November 2025

Joachim Eeckhout
FirstBack
12345678
Next Last
A daily 5-min biotech briefing

Biotech Snap

A daily 5-min biotech briefing

Home

Posts

© 2026 Knowbio GmbH.

Privacy policy

Terms of use

Powered by beehiiv